Accolade, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended August 31, 2021
October 07, 2021 at 04:05 pm EDT
Share
Accolade, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended August 31, 2021. For the quarter, the company reported revenue of $73,288,000 against $36,788,000 a year ago. Loss from operations was $74,444,000 against $12,902,000 a year ago. Net loss was $62,364,000 against $15,371,000 a year ago. Basic and diluted net loss per share was $0.97 against $0.47 a year ago.
For the six months, the company reported revenue of $132,815,000 against $72,682,000 a year ago. Loss from operations was $122,459,000 against $25,527,000 a year ago. Net loss was $111,071,000 against $29,331,000 a year ago. Basic and diluted net loss per share was $1.81 against $1.45 a year ago.
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, womenâs health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
ACCOLADE, INC. 
